Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/114083
DC FieldValueLanguage
dc.contributor.authorFilgueira, Tayrine Ordonio-
dc.contributor.authorCarvalho, Paulo Roberto Cavalcanti-
dc.contributor.authorde Sousa Fernandes, Matheus Santos-
dc.contributor.authorCastoldi, Angela-
dc.contributor.authorTeixeira, Ana-
dc.contributor.authorde Albuquerque, Renata Bezerra-
dc.contributor.authorde Lima-Filho, José Luiz-
dc.contributor.authorSouto, Fabrício Oliveira-
dc.date.accessioned2024-03-19T10:21:46Z-
dc.date.available2024-03-19T10:21:46Z-
dc.date.issued2022-
dc.identifier.issn1664-3224pt
dc.identifier.urihttps://hdl.handle.net/10316/114083-
dc.description.abstractCOVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high release of pro-inflammatory chemokines and cytokines, leading to severe systemic disorders. Further, evidence has shown that recovered COVID-19 patients still have some symptoms and disorders from COVID-19. Physical exercise can have many health benefits. It is known to be a potent regulator of the immune system, which includes frequency, intensity, duration, and supervised by a professional. Given the confinement and social isolation or hospitalization of COVID-19 patients, the population became sedentary or opted for physical exercise at home, assuming the guarantee of the beneficial effects of physical exercise and reducing exposure to SARS-CoV-2. This study aimed to investigate the effects of a supervised exercise protocol and a home-based unsupervised exercise protocol on chemokine and cytokine serum levels in recovered COVID-19 patients. This study was a prospective, parallel, two-arm clinical trial. Twenty-four patients who had moderate to severe COVID-19 concluded the intervention protocols of this study. Participants were submitted to either supervised exercise protocol at the Clinical Hospital of the Federal University of Pernambuco or home-based unsupervised exercise for 12 weeks. We analyzed serum levels of chemokines (CXCL8/IL-8, CCL5/RANTES, CXCL9/MIG, CCL2/MCP-1, and CXCL10/IP-10) and cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, and IFN-γ). Before the interventions, no significant differences were observed in the serum levels of chemokines and cytokines between the supervised and home-based unsupervised exercise groups. The CXCL8/IL-8 (p = 0.04), CCL2/MCP-1 (p = 0.03), and IFN-γ (p = 0.004) levels decreased after 12 weeks of supervised exercise. In parallel, an increase in IL-2 (p = 0.02), IL-6 (p = 0.03), IL-4 (p = 0.006), and IL-10 (p = 0.04) was observed after the supervised protocol compared to pre-intervention levels. No significant differences in all the chemokines and cytokines were found after 12 weeks of the home-based unsupervised exercise protocol. Given the results, the present study observed that supervised exercise was able to modulate the immune response in individuals with post-COVID-19, suggesting that supervised exercise can mitigate the inflammatory process associated with COVID-19 and its disorders.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES)pt
dc.relationCAPES (88887.470105/ 2019-00)pt
dc.relationFACEPE (BFP-0102-1.11/19)pt
dc.relationCNPq (159958/2019-9)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectsupervised exercise protocolpt
dc.subjecthome-based exercisept
dc.subjectimmune biomarkerspt
dc.subjectchemokinespt
dc.subjectcytokinespt
dc.subjectCOVID-19pt
dc.subject.meshHumanspt
dc.subject.meshInterleukin-10pt
dc.subject.meshInterleukin-8pt
dc.subject.meshInterleukin-6pt
dc.subject.meshInterleukin-4pt
dc.subject.meshInterleukin-2pt
dc.subject.meshProspective Studiespt
dc.subject.meshSARS-CoV-2pt
dc.subject.meshChemokinespt
dc.subject.meshCytokinespt
dc.subject.meshCOVID-19pt
dc.titleThe impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patientspt
dc.typearticle-
degois.publication.firstPage1051059pt
degois.publication.titleFrontiers in Immunologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fimmu.2022.1051059pt
degois.publication.volume13pt
dc.date.embargo2022-01-01*
uc.date.periodoEmbargo0pt
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.openairetypearticle-
crisitem.author.researchunitCIDAF - Research Unit for Sport and Physical Activity-
crisitem.author.orcid0000-0003-1498-949X-
Appears in Collections:FCDEF - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

34
checked on Jul 31, 2024

Download(s)

21
checked on Jul 31, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons